================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

                DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
                                 MARCH 31, 2005

                               TRANSGENOMIC, INC.
             (Exact name of registrant as specified in its charter)

              Delaware                                     000-30975
       (State of Formation)                        (Commission File Number)

                                    911789357
                      (IRS Employer Identification Number)

            12325 Emmet Street
               Omaha, NE                                   68164
   (Address of principal executive offices)              (Zip Code)

                                 (402) 452-5400
              (Registrants' telephone number, including area code)

                                 Not applicable

          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities
     Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange
     Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e(c))

================================================================================



ITEM 3.01  NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
           STANDARD.

     On March 31, 2005, the Registrant received notice from The NASDAQ Stock
Market that for the last 30 days the bid price of Registrant's common stock has
closed below the minimum $1.00 per share requirement for continued inclusion
under Marketplace Rule 4450(a)(5). In accordance with Marketplace Rule
4450(e)(2), Registrant will be provided 180 calendar days, or until September
27, 2005, to regain compliance. The Registrant has not determined an action or
response to the notice as of the time of this filing.

                                        2


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                      TRANSGENOMIC, INC.

                                                      By /s/ Michael Summers
                                                         -----------------------
                                                         Michael Summers
                                                         Chief Financial Officer

April 4, 2005

                                        3